ACTIVE ANKYLOSING SPONDYLITIS
Clinical trials for ACTIVE ANKYLOSING SPONDYLITIS explained in plain language.
Never miss a new study
Get alerted when new ACTIVE ANKYLOSING SPONDYLITIS trials appear
Sign up with your email to follow new studies for ACTIVE ANKYLOSING SPONDYLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill trial offers hope for stiff, painful spine condition
Disease control Recruiting nowThis large, late-stage study is testing whether a new tablet called VC005 can help control the painful inflammation and stiffness of active ankylosing spondylitis. It will involve 420 adults with the condition to see if the drug safely improves their symptoms. The main goal is to…
Matched conditions: ACTIVE ANKYLOSING SPONDYLITIS
Phase: PHASE3 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Drug safety watch: tracking arthritis medication in real patients
Disease control Recruiting nowThis study is monitoring the safety and effectiveness of the arthritis medication Xeljanz XR in routine medical practice in Korea. It will follow at least 200 adults with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis who are already prescribed this medicati…
Matched conditions: ACTIVE ANKYLOSING SPONDYLITIS
Sponsor: Pfizer • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC